2020
DOI: 10.1016/j.cmi.2019.09.017
|View full text |Cite
|
Sign up to set email alerts
|

Portable molecular diagnostic instruments in microbiology: current status

Abstract: Background: Mobile microbiology is an evolving concept that has the potential to reduce morbidity and mortality associated with infectious diseases on a global level. Molecular methods used in the context of mobile microbiology ensure rapid and accurate aetiological diagnostics and allow timely initiation of clinical care. The great majority of published data regarding molecular diagnostics in mobile laboratories have focused on emerging viral infections and using laboratory-developed assays. Use of clinically… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 15 publications
(6 citation statements)
references
References 50 publications
0
6
0
Order By: Relevance
“…As the present work was a proof of principle, a lab PCR was used to verify the feasibility of the system. Portable PCR have already been presented in [14,18,[23][24][25], and the aim of future work is to miniaturize the system for direct PCR detection in order to obtain a transportable system for in-field measurements.…”
Section: Discussionmentioning
confidence: 99%
“…As the present work was a proof of principle, a lab PCR was used to verify the feasibility of the system. Portable PCR have already been presented in [14,18,[23][24][25], and the aim of future work is to miniaturize the system for direct PCR detection in order to obtain a transportable system for in-field measurements.…”
Section: Discussionmentioning
confidence: 99%
“…The advantages are numerous: such as a faster turnaround time for the clinician and an excellent clinical performance at affordable prices. Today, molecular testing is increasingly taking the place of conventional culture-based methods [25][26][27].…”
Section: Cleaning and Disinfectionmentioning
confidence: 99%
“…However, endemic regions may qualify for a price discount and the GeneXpert platform is already established in many LMIC for tuberculosis and other pathogens, such as HIV and other sexually-transmitted infections (73)(74)(75)(76). HBV and HCV cartridges are available for viral load (VL) quantification in serum/plasma or by fingerstick (HCV only) and thus are applicable as a near-patient POC test that would be performed in a healthcare facility for patient management purposes.…”
Section: Nucleic-acid-based Rdtmentioning
confidence: 99%